Loading clinical trials...
Loading clinical trials...
High Dose Inhaled Nitric Oxide Therapy in Critically Ill Patients With Pneumonia: a Pilot, Double-blinded, Randomized, Controlled Trial
Conditions
Interventions
High dose inhaled nitric oxide
Sham treatment
+1 more
Locations
1
United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Start Date
February 23, 2026
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
March 4, 2026
NCT07428759
NCT06743529
NCT07188350
NCT06667999
NCT07298720
NCT07478380
Lead Sponsor
Massachusetts General Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions